Do the benefits of subcutaneous immunoglobulin therapy for secondary hypogammaglobulinemia in ANCA vasculitis extend beyond infection prevention?

Churilla, Bryce M; Aqeel, Faten; Azar, Antoine; Antiochos, Brendan; Seo, Philip; Hellmann, David B; Geetha, Duvuru

Churilla, Bryce M; Aqeel, Faten; Azar, Antoine; Antiochos, Brendan; Seo, Philip; Hellmann, David B; Geetha, Duvuru.

Afiliación

Churilla BM; Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Aqeel F; Department of Internal Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Azar A; Department of Internal Medicine, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Antiochos B; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Seo P; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hellmann DB; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Geetha D; Department of Internal Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: dgeetha1@jhmi.edu.

Kidney Int ; 102(2): 444-445, 2022 08.

Article en En | MEDLINE | ID: mdl-35870815

Asunto(s)

Agammaglobulinemia; Inmunización Pasiva; Vasculitis; Agammaglobulinemia/terapia; Anticuerpos Anticitoplasma de Neutrófilos; Humanos; Rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vasculitis / Inmunización Pasiva / Agammaglobulinemia Límite: Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google